Mr. Brent Ashton reports

COVALON ANNOUNCES CONFERENCE CALL TO DISCUSS THIRD QUARTER FISCAL 2026 RESULTS

Covalon Technologies Ltd. will release its Q3 fiscal 2026 results on Thursday, Aug. 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, Aug. 27, 2026, at 8:30 a.m ET.

To listen and participate via the conference call, please dial:

North America toll-free:  1-833-461-5787

International toll:  1-585-542-9983

Meeting ID:   768174807

Participants will be able to ask questions during the Q&A (question-and-answer) portion of the conference call either by asking them on the call or by submitting them using the chat function on the webcast.

A recording of the call will be available on the company's website under news and events on the investors tab.

About Covalon Technologies Ltd.

Covalon is a leading medtech company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. The company's expertise spans advanced wound care, vascular access and surgical consumables, with a strong focus on enhancing healing, reducing health-care-associated infections (HAIs) and protecting skin integrity. The company's solutions are designed for patients and made for care providers. The company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF).

We seek Safe Harbor.